Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, as the other poster pointed out, the last two PR's came at 6pmest so there is still time. Either way, I'm happy to be on board here. This is shaping up to be a great play. Thanks again Chevy for the tip!
Got the alert this morning and was going to buy it at the open. When I logged into my acct it was restricted (all fixed now) and I couldn't place an order. Figures. Congrats to you. :)
I noticed that someone has been accumulating this stock over the last few weeks. Wonder why?
The ask just ut'ed to .10
Good Morning All.
GM All.
DLAV has been hot today. I had an order in this morning and chose to cancel and forget about it when I didn't get filled. Figures.
GLIF - .03 now and UP 50%. Not in.
GLIF (.024) (Grant Life Sciences in-licenses HPV DNA-based test from Alphagenics
Tuesday, November 13 2007 12:33 PM, EST Business Wire "US Press Releases "
LOS ANGELES --(BUSINESS WIRE)--
Grant Life Sciences Inc. (OTC Bulletin Board: GLIF) announced today that it has signed a final agreement with Alphagenics Diaco Biotechnologies S.r.l. ( Italy ) to exclusively in-license the manufacturing and marketing rights to Alphagenics' molecular diagnostic test for human papillomaviruses (HPVs) in China and the United States and non-exclusively in all other countries.
The Alphagenics HPV test in-licensed by Grant is a DNA-based diagnostic that uses standard molecular diagnostic equipment found in most commercial laboratories. Alphagenics' HPV DNA test complements the HPV blood test that Grant has been developing to detect the presence of antibodies produced only by cancer-causing HPV types. There are some 100 types of HPV; however, only about 7 to 15 HPV-types cause most cervical cancers. While a blood-based test to detect precancerous evidence and cancer of the cervix is still viewed by Grant Life Sciences as the preferred test-methodology to address the needs of the developing world, molecular (DNA) testing is currently the approved test protocol in both the U.S. and Europe to identify the presence of different subtypes of HPV in the cervix.
"Our introduction of the Alphagenics HPV test not only will allow commercial laboratories to provide molecular testing but will also complement the current introduction of vaccines against HPVs," said Dr. Hun-Chi Lin, President and Chief Scientist, Grant Life Sciences. "The current approved vaccine in the U.S. provides for inoculation against four types of HPV for use in girls and women 9-to-26 years of age, who presumably have not been exposed to the viruses. However, women who have reached sexual maturity and have not been exposed to one of the four HPV-types may benefit from the vaccination, according to the Advisory Committee on Immunization Practices (ACIP). Consequently, the Alphagenics test will be able to be used by the balance of the female population to determine exposure and the possible use of the vaccine if found negative. Further both vaccines on the market (GSK's vaccine is approved for Australia for ages 10-to-45 and Merck's vaccine is approved in the U.S. for ages 9-to-26) only confer protection against HPV oncogenic types 16 and 18. While these types are predominant (approximately 60+%) in the Caucasian market, there are other types that play significant roles in the Asian, African, Indian, and Hispanic populations. Fortunately, the Alphagenics test is designed to test for all the serotypes of oncogenic HPV."
In addition, Dr. Lin said that the Alphagenics test will be able to be used in the current gynecological regimen to help qualify Pap test results in the case of ambiguous readings, at a cost less than the current approved molecular test. Grant expects to launch the Alphagenics HPV DNA-based test in the Asian and Indian markets during the first quarter of 2008 as an Analyte-Specific Reagent (ASR) to reference laboratories.
About Alphagenics Diaco Biotechnologies S.r.l.
Established in July 1996 , Alphagenics Diaco Biotechnologies is one of the most specialized companies in Italy in the use of technical innovation in molecular biology for the production of kits for clinical and research use in oncology, bacteriology, virology and mycology.
About Grant Life Sciences Inc.
Grant Life Sciences engages in research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of diseases with emphasis on women's health, infectious diseases, and cancers.
Forward-Looking Safe Harbor Statement
With the exception of historical information, the matters discussed in this press release are "forward-looking statements" that involve a number of risks and uncertainties. The actual future results of Grant Life Sciences could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities, results of clinical trials, and market acceptance of the Company's products. In some cases, "forward-looking statements" can be identified by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," or other comparable terminology. Although Grant Life Sciences believes that the expectations reflected in the "forward-looking" statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such "forward-looking statements" will be achieved. Grant Life Sciences undertakes no duty to update any of the "forward-looking statements," whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such "forward-looking statements." For further risk factors associated with our Company, review our SEC filings.
Source: Grant Life Sciences Inc.
LOL. I didn't know what all the "Timberrrrr" was about until catching up on some of the news. Ouch!!
LOL. eom
Yep. Still holding my shares as their plan unfolds.
CCWW: It was reduced...
From the 9/18 Press Release:
Cable & Co. Worldwide Announces Reduction to Share Structure, and Reduces Previously Announced Reverse Split
Market Wire "US Press Releases "
WESTPORT, CT -- (MARKET WIRE) -- 09/18/07 -- Cable & Co. Worldwide (PINKSHEETS: CCWW) announces that the Company and a majority of its shareholders have decided to reduce the previously announced planned reverse stock split of the Company's common shares to a final plan of one (1) new common share for each 150 now outstanding. By improving the reverse split ratio from the 1:600 previously announced, the Company believes this will provide the liquidity in the marketplace the Company wishes to maintain.
The Company and a majority of its shareholders have also agreed to reduce the number of authorized shares from the current 1,500,000,000 to 150 million. The Company feels that after the affects of the reverse split are completed, the available but unissued authorized shares will provide sufficient capital support for growth and potential future acquisitions.
The result of these actions will leave a total of 9,990,750 issued and outstanding shares, of which approximately 2,297,873 will be available in the open market. The remaining 7,692,877 are owned by affiliates of the Company and their resale is restricted.
CCWW is also announcing that it is proceeding with its previously announced business plans, more details of which will be provided in the coming weeks. The Company will be requesting a new CUSIP number and trading symbol, in support of its planned name change to Marketing & Research Corp. The Company is negotiating to acquire select private companies in the fields of market research, Hollywood box office tracking, political poll analysis and employee incentive performance programs, and hopes to make its first acquisition announcement shortly.
The Company expects to complete all required SEC compliance filings associated with the above actions within the next 45 days.
About Cable & Co. Worldwide, Inc. and LifeHealthCare, Inc.
Cable & Co. Worldwide, Inc. is a shell with no operating business other than LifeHealthCare, Inc. LifeHealthCare, Inc. intends to develop and commercialize innovative over-the-counter, non-prescriptive dental care products.
The last two... 1 million and 1.3 went through at the ask and we lost one MM. The 1.6 went through at the bid.
Same here. Watching UHCR too.
I show last sale before close as 500,000 @ .0018
CCWW gapping pre-market on news released yesterday AH:
Press Release Source: Cable & Co. Worldwide, Inc.
CCWW Is Acquiring Aspen Media as Launch to Its Business Plan With $5M in Annual Revenues
Tuesday November 6, 6:00 pm ET
WESTPORT, CT--(MARKET WIRE)--Nov 6, 2007 -- Cable & Co. Worldwide, Inc. ("Cable") (Other OTC:CCWW.PK - News) has reached an understanding to purchase Quantum Research Services, Inc., doing business as Aspen Media and Market Research, Ltd., a Colorado corporation ("Quantum"). www.aspenonnet.com
ADVERTISEMENT
Headquartered in Colorado, Quantum is in the business of providing market research services, including research field services; circulation - subscription renewal and acquisitions; sales lead qualification program and specialized services; relational database creation and list consolidation; and print-to-electronic file conversion. Quantum had sales of $5.4 Million with an adjusted EBITDA of $405,000 for the year ended June 30, 2007. The closing of the Acquisition remains subject to various conditions, and it is currently anticipated that the Acquisition will be consummated in or about January 2008. Additional news regarding Cable's business plan will be released later this week and over the course of the next several weeks.
About Cable & Co.
Cable currently owns LifeHealth Care, Inc. LifeHealthCare, Inc. intends to develop and commercialize innovative over-the-counter, non-prescriptive dental care products.
About Quantum
Quantum currently provides consumer research services to the telecommunications, automotive, healthcare, banking and cable industries and provides a circulation and research service for Business-to-Business for these same industries.
Forward-Looking Statements: The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the Company and its subsidiaries. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by the Company may differ materially from these statements due to a number of factors. Any forward-looking statements speak only as of the date made. Statements made in this document that are not purely historical are forward-looking statements, including any statements as to beliefs, plans, expectations, or intentions regarding the future. Risk factors that may cause results to differ from projections include, without limitation, loss of suppliers, loss of customers, inadequate capital, competition, loss of key executives, declining prices, and other economic factors. The Company assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. You should independently investigate and fully understand all risks before making investment decisions.
Contact:
Contact for further information:
Gary Stein
steincorp007@yahoo.com
--------------------------------------------------------------------------------
Source: Cable & Co. Worldwide, Inc.
Great news. Looking forward to hearing more about their biz plan.
Thx! Those .004s I looked at last week would have been so sweet. Oh well, on to find the next one.
Are you in? Decided to buy at .03. Should gap tomorrow.
Still in DTGP?
AEi Transportation Holdings, Inc., Formerly Doll Technology Group, Inc., Completes Merger with Southland Holding Corp.
SEATTLE--(BUSINESS WIRE)--AEi Transportation Holdings, Inc., formerly known as Doll Technology Group, Inc. (Pink Sheets:DTGP) (“AEiT” or the “Company”), today announced it has completed its merger agreement with Southland Holding Corp., an aviation and transportation services company (“Southland”), resulting in Southland Holding Corp. continuing as a wholly-owned subsidiary of the Company.
AEiT’s merger with Southland is part of the Company’s strategic plan to position itself in the multi-billion dollar transportation sector. The Company had previously announced the name change to AEi Transportation Holdings, Inc. and anticipates a new trading symbol shortly.
AEiT expects to announce a new management team, comprised of individuals having a distinguished business track record with years of experience managing private and publicly traded companies, with extensive management focusing on facilitating airline operations.
AEiT is proud to announce the retention of U.S.-based Corporate Stock Transfer as its corporate transfer agent. Founded in 1985, Corporate Stock Transfer (“CST”) serves domestic and international public companies, providing complete stock transfer services, and escrow agent services with unparalleled customer retention.
Forward-Looking Statements
This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.
Contacts
For Doll Technology Group, Inc., Seattle
AEi Transportation Holdings, Inc
Media & Investor Relations:
Joseph J. Malone, 786-375-0556Information@EquityDigest.com
www.EquityDigest.com
Yep. It was up over 1000% earlier.
I use ZECCO and haven't had any problems thus far.
TUIC - .025 now and it was at .001 just 4 biz days ago. Geez.
Same here. I added to my position today.
Yep. I watched it on Friday but didn't get in. Nice move on that one.
Joined you guys.
Joined you guys.
Agreed.
Nice news!
There seems to be a number of stocks running up huge on no news (GBNW, SKYL, SNQS, etc) and then pulling back to where they started or lower with little to no volume thereafter.
Yep. It was up 600% today before pulling back.
ROTB(.10)US-China Entrepreneur Named Rotoblock CEO
10/31/2007
SANTA ROSA, Calif., Oct 31, 2007 (BUSINESS WIRE) --
Rotoblock Corporation (OTCBB:ROTB), developer of an advanced Oscillating Piston Engine (OPE) technology, announced today that Chinese-American entrepreneur Mr. Liu Chien-Chih has agreed to join as Chief Executive Officer.
Mr. Liu has over 15 years' experience in international trade, marketing and manufacturing. Born in Taiwan, Mr. Liu immigrated with his family to the USA at the age of 10. Fluent in English and several Chinese dialects, Mr. Liu earned a Bachelor of Science Degree in Chemical Engineering from the University of California at Berkeley. Since that time he has spent much of his career capitalizing on new ideas and technologies and sees an opportunity with Rotoblock.
"China is going through an industrial revolution and I see the market for small engines and advanced drive train development exploding with new technologies and economic growth," said Mr. Liu. "Rotoblock will explore the commercialization of the oscillating piston engine in China as well as pursue new opportunities for developing new products, commercializing the brand and distributing it worldwide."
Prior to joining Rotoblock, Mr. Liu served for more than five years as a Vice President for Tianyi Group of Nanjing, China, a multi-billion dollar conglomerate involved in the manufacturing of automotive components and commercial equipment with over 10 subsidiaries. Mr. Liu served a variety of roles with Tianyi Group, which operates several factories in China. He managed Tianyi's extensive portfolio of real estate developments and other investments. He also managed the subsidiary Hikom/Goettel, one of the largest manufacturers of air conditioning in China. Hikom is the sole sponsor of the Shanghai Sharks Professional Basketball team, for which Yao Ming played before being recruited to the NBA.
"I am committed to devoting 100 percent of my time to growing Rotoblock," said Mr. Liu. "With the experience and relationships developed with Tianyi Group, I believe I can take Rotoblock to new levels."
"I congratulate Mr. Liu on his new venture and wish him nothing but success," said Tianyi Group Chairman and CEO Mr. Jiang Guobei. "I have every confidence in his ability to grow this company. Mr. Liu has a keen eye for new opportunities and taking them to completion and he will be missed here at Tianyi Group."
Rotoblock
About Rotoblock Corporation -- Rotoblock is focused on the development of leading-edge power train technologies including the development of its patented Oscillating Piston Engine technology. Rotoblock has signed a licensing agreement with OBVIO! Automotoveiculos S.A. of Brazil. The company was incorporated in Nevada and is headquartered in Santa Rosa, California. The Company has full rights to the patents of the Oscillating Piston Engine and believes the OPE technology has useful applications in an endless number of areas where its powerful, lightweight, efficient design are in ever-increasing demand. Visit Rotoblock's corporate website for details about the company, technology, and regulatory filings. The address is: http://www.rotoblock.com.
Safe Harbor For Forward-Looking Statements
Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors over which Rotoblock Corporation has little or no control.
SOURCE: Rotoblock Corporation
Rotoblock Corporation Tony R. Collins, 877-511-0110 (Toll Free)
in SNQS too.
That is probably why it has taken so long.
is it an AON order?
n/m. already posted.
yeppers. :)
Same here. Zecco is a secondary acct I use but I've had buy orders with my main acct too that didn't show.
I've had buy orders too that didn't show.